Banker and real-estate developer Ronald Paul began his community service early. As a student at the University of Maryland, he raised $30,000 for the American Cancer Society and became the youngest member of the society’s board. Today Paul is chairman and CEO of EagleBank, and the Ronald Paul Companies develop and manage residential and commercial properties in the Washington area. As his businesses grew, Paul continued to work for community causes. In 2003, he started the EagleBank Foundation golf classic, which has raised more than $900,000 for local hospitals helping cancer patients.
Then in 1984, Paul went for a routine physical for a life-insurance policy—and failed one of the lab tests. A mistreated childhood illness had likely damaged his kidneys irreparably. When Paul’s wife, Joy, heard the news, she turned to the National Kidney Foundation for information and discovered a loving, supportive network that helped both her and her husband through the ordeals ahead.
Ron Paul, a self-described “give-back” guy, had found a new cause. Over the past 25 years, he has raised more than $3 million for kidney research and worked to enhance access to dialysis and other therapies for kidney disease.
Paul received his first kidney transplant in 1990, from his brother Steven. In 2009, he needed another—despite anti-rejection drugs, the lifespan of a donated kidney is less than 20 years. This time, the donor was Kathy McCallum, partner and chief financial officer of his company. “Ever since I’ve known him, he’s done charity work,” McCallum says. She didn’t think twice about the donation: “I only had to get the permission of my family and my dogs, and they gave me a thumbs-up.”
Paul is doing well. Anti-rejection drugs have greatly improved, he says. And he has yet another cause: lobbying to change Medicaid rules that limit coverage of anti-rejection drugs to only two years. Without the drugs, donated kidneys will fail, putting patients back on costly and debilitating dialysis.
Ron Paul the banker also goes out of his way to help community groups. When Whitman-Walker Clinic was in financial crisis, the bank that came to the rescue was EagleBank.
Paul has a favorite saying: “You make a living by what you earn. You make a life by what you give.”
This feature first appeared in the January 2011 issue of The Washingtonian.
Washingtonian of the Year 2010: Ronald Paul
A champion for kidney research
>> See All Washingtonians of the Year
Banker and real-estate developer Ronald Paul began his community service early. As a student at the University of Maryland, he raised $30,000 for the American Cancer Society and became the youngest member of the society’s board. Today Paul is chairman and CEO of EagleBank, and the Ronald Paul Companies develop and manage residential and commercial properties in the Washington area. As his businesses grew, Paul continued to work for community causes. In 2003, he started the EagleBank Foundation golf classic, which has raised more than $900,000 for local hospitals helping cancer patients.
Then in 1984, Paul went for a routine physical for a life-insurance policy—and failed one of the lab tests. A mistreated childhood illness had likely damaged his kidneys irreparably. When Paul’s wife, Joy, heard the news, she turned to the National Kidney Foundation for information and discovered a loving, supportive network that helped both her and her husband through the ordeals ahead.
Ron Paul, a self-described “give-back” guy, had found a new cause. Over the past 25 years, he has raised more than $3 million for kidney research and worked to enhance access to dialysis and other therapies for kidney disease.
Paul received his first kidney transplant in 1990, from his brother Steven. In 2009, he needed another—despite anti-rejection drugs, the lifespan of a donated kidney is less than 20 years. This time, the donor was Kathy McCallum, partner and chief financial officer of his company. “Ever since I’ve known him, he’s done charity work,” McCallum says. She didn’t think twice about the donation: “I only had to get the permission of my family and my dogs, and they gave me a thumbs-up.”
Paul is doing well. Anti-rejection drugs have greatly improved, he says. And he has yet another cause: lobbying to change Medicaid rules that limit coverage of anti-rejection drugs to only two years. Without the drugs, donated kidneys will fail, putting patients back on costly and debilitating dialysis.
Ron Paul the banker also goes out of his way to help community groups. When Whitman-Walker Clinic was in financial crisis, the bank that came to the rescue was EagleBank.
Paul has a favorite saying: “You make a living by what you earn. You make a life by what you give.”
This feature first appeared in the January 2011 issue of The Washingtonian.
Subscribe to Washingtonian
Follow Washingtonian on Twitter
More>> Capital Comment Blog | News & Politics | Party Photos
Most Popular in News & Politics
See a Spotted Lanternfly? Here’s What to Do.
Meet DC’s 2025 Tech Titans
What Happens After We Die? These UVA Researchers Are Investigating It.
GOP Candidate Quits Virginia Race After Losing Federal Contracting Job, Trump Plans Crackdown on Left Following Kirk’s Death, and Theatre Week Starts Thursday
USDA Spent $16,400 on Banners to Honor Trump and Lincoln
Washingtonian Magazine
September Issue: Style Setters
View IssueSubscribe
Follow Us on Social
Follow Us on Social
Related
Why Can You Swim in the Seine but Not the Potomac River?
This DC Woman Might Owe You Money
Why a Lost DC Novel Is Getting New Attention
These Confusing Bands Aren’t Actually From DC
More from News & Politics
How to Pick a Good Title-and-Settlement Company in the DC Area
Weird Press Conference Ends Trump’s Vacation From Offering Medical Advice, Kimmel Goes Back to Work Tonight, and DC Man Arrested for Shining Laser Pointer at Marine One
Why Can You Swim in the Seine but Not the Potomac River?
Nominations Are Now Open for 500 Most Influential People List
Trump and Musk Reunite, Administration Will Claim Link Between Tylenol and Autism, and Foo Fighters Play Surprise Show in DC
This DC Woman Might Owe You Money
A New Exhibition Near the White House Takes a High-Tech Approach to a Fundamental Question: What Is the American Dream?
Want to See What Could Be Ovechkin’s Last Game in DC? It’s Going to Cost You.